دورية أكاديمية

Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.

التفاصيل البيبلوغرافية
العنوان: Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk.
المؤلفون: Permuth JB; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Pirie A; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Ann Chen Y; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA., Lin HY; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA., Reid BM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Chen Z; Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL, USA., Monteiro A; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Dennis J; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Mendoza-Fandino G; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Anton-Culver H; Department of Epidemiology, Director of Genetic Epidemiology Research Institute, UCI School of Medicine, University of California Irvine, Irvine, CA, USA., Bandera EV; Cancer Prevention and Control Program, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA., Bisogna M; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brinton L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Brooks-Wilson A; Canada's Michael Smith Genome Sciences Centre, BC Cancer Agency, Vancouver BC, Canada.; Department of Biomedical Physiology and Kinesiology, Simon Fraser University, Burnaby, BC, Canada., Carney ME; Department of Obstetrics and Gynecology, John A Burns School of Medicine, University of Hawaii, Honolulu, Hawaii, USA., Chenevix-Trench G; Genetics and Computational Biology Department, QIMR Berghofer Medical Research Institute, Queensland, Australia., Cook LS; Division of Epidemiology and Biostatistics, Department of Internal Medicine, University of New Mexico, Albuquerque, New Mexico, USA., Cramer DW; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA., Cunningham JM; Department of Laboratory of Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Cybulski C; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., D'Aloisio AA; Social and Scientific Systems, Inc, Durham, NC, USA., Anne Doherty J; Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Hanover, NY, USA., Earp M; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Edwards RP; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee- Womens Research Institute & University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA., Fridley BL; Department of Biostatistics, University of Kansas Medical Center, Kansas City, KS, USA., Gayther SA; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Gentry-Maharaj A; Women's Cancer, Institute for Women's Health, University College London, London, UK., Goodman MT; Cancer Prevention and Control, Samuel Oshin Comprehensive Cancer Institute, Cedars- Sinai Medical Center, Los Angeles, CA, USA.; Community and Population Health Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA., Gronwald J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Hogdall E; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark and Molecular Unit, Department of Pathology, Herlev Hospital, University of Copenhagen, Copenhagen, Denmark., Iversen ES; Department of Statistical Science, Duke University, Durham, NC, USA., Jakubowska A; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Jensen A; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark., Karlan BY; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Kelemen LE; Department of Public Health Sciences, Medical University of South Carolina College of Medicine, Charleston, SC, USA., Kjaer SK; Department of Virus, Lifestyle and Genes, Danish Cancer Society Research Center, Copenhagen, Denmark.; Department of Gynaecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Kraft P; Program in Genetic Epidemiology and Statistical Genetics, Harvard TH Chan School of Public Health, Boston, MA, USA., Le ND; Cancer Control Research, BC Cancer Agency, Vancouver, BC, Canada., Levine DA; Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lissowska J; Department of Cancer Epidemiology and Prevention, The Maria Sklodowska-Curie Memorial Cancer Center, Warsaw, Poland., Lubinski J; International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University, Szczecin, Poland., Matsuo K; Division of Molecular Medicine, Aichi Cancer Center Research Institute, Nagoya, Aichi, Japan., Menon U; Women's Cancer, Institute for Women's Health, University College London, London, UK., Modugno R; Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.; Ovarian Cancer Center of Excellence, Womens Cancer Research Program, Magee- Womens Research Institute & University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA.; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA, USA., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Cancer Institute, Buffalo, NY, USA., Nakanishi T; Department of Gynecologic Oncology, Aichi Cancer Center Central Hospital, Nagoya, Aichi, Japan., Ness RB; The University of Texas School of Public Health, Houston, TX, USA., Olson S; Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York,NY, USA., Orlow I; Memorial Sloan Kettering Cancer Center, Department of Epidemiology and Biostatistics, New York,NY, USA., Pearce CL; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.; Department of Epidemology,University of Michigan School of Public Health, Ann Arbor, MI, USA., Pejovic T; Department of Obstetrics and Gynecology, Oregon Health and Science University, Portland, OR, USA.; Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Poole EM; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Ramus SJ; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Anne Rossing M; Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Epidemiology, University of Washington, Seattle, WA, USA., Sandler DP; Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA., Shu XO; Vanderbilt University School of Medicine, Nashville, TN, USA., Song H; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Taylor JA; Epidemiology Branch, Division of Intramural Research, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC, USA., Teo SH; Cancer Research Malaysia, Subang Jaya, Malaysia.; University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia., Terry KL; Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Boston, Massachusetts, USA., Thompson PJ; Women's Cancer Program at the Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, California., Tworoger SS; Channing Division of Network Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Webb PM; Population Health Department, QIMR Berghofer Medical Research Institute, Herston, QLD, Australia., Wentzensen N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda MD, USA., Wilkens LR; Cancer Epidemiology Program, University of Hawaii Cancer Center, Hawaii, USA., Winham S; Department of Health Science Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA., Woo YL; Department of Obstetrics and Gynaecology, University Malaya Medical Centre, University Malaya, Kuala Lumpur, Malaysia., Wu AH; Department of Preventive Medicine, Keck School of Medicine, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Yang H; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda MD, USA., Zheng W; Vanderbilt Epidemiology Center and Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, TN, USA., Ziogas A; Department of Epidemiology, University of California Irvine, Irvine, CA, USA., Phelan CM; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA., Schildkraut JM; Department of Community and Family Medicine, Duke University Medical Center, Durham, NC, USA.; Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC, USA., Berchuck A; Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina, USA, Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk., Goode EL; Department of Health Science Research, Division of Epidemiology, Mayo Clinic, Rochester, MN, USA., Pharoah PD; Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK.; Department of Oncology, University of Cambridge, Strangeways Research Laboratory, Cambridge, UK., Sellers TA; Department of Cancer Epidemiology, Moffitt Cancer Center, Tampa, FL, USA.
مؤلفون مشاركون: AOCS Study Group, Australian Cancer Study (Ovarian Cancer), Ovarian Cancer Association Consortium
المصدر: Human molecular genetics [Hum Mol Genet] 2016 Aug 15; Vol. 25 (16), pp. 3600-3612. Date of Electronic Publication: 2016 Jul 04.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9208958 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2083 (Electronic) Linking ISSN: 09646906 NLM ISO Abbreviation: Hum Mol Genet Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Oxford, England ; New York : IRL Press at Oxford University Press, c1992-
مواضيع طبية MeSH: Actins/*genetics , Biotinidase/*genetics , Keratin-13/*genetics , Neoplasms, Glandular and Epithelial/*genetics , Ovarian Neoplasms/*genetics , Receptor, Melanocortin, Type 2/*genetics, Carcinoma, Ovarian Epithelial ; Exome/genetics ; Female ; Genetic Predisposition to Disease ; Genome-Wide Association Study ; Genotype ; Humans ; Neoplasm Proteins/genetics ; Neoplasms, Glandular and Epithelial/pathology ; Ovarian Neoplasms/pathology ; Polymorphism, Single Nucleotide
مستخلص: Rare and low frequency variants are not well covered in most germline genotyping arrays and are understudied in relation to epithelial ovarian cancer (EOC) risk. To address this gap, we used genotyping arrays targeting rarer protein-coding variation in 8,165 EOC cases and 11,619 controls from the international Ovarian Cancer Association Consortium (OCAC). Pooled association analyses were conducted at the variant and gene level for 98,543 variants directly genotyped through two exome genotyping projects. Only common variants that represent or are in strong linkage disequilibrium (LD) with previously-identified signals at established loci reached traditional thresholds for exome-wide significance (P < 5.0 × 10  -7 ). One of the most significant signals (P all histologies  = 1.01 × 10  -13 ;P serous  = 3.54 × 10  -14 ) occurred at 3q25.31 for rs62273959, a missense variant mapping to the LEKR1 gene that is in LD (r 2  = 0.90) with a previously identified 'best hit' (rs7651446) mapping to an intron of TIPARP. Suggestive associations (5.0 × 10  -5  > P≥5.0 ×10  -7 ) were detected for rare and low-frequency variants at 16 novel loci. Four rare missense variants were identified (ACTBL2 rs73757391 (5q11.2), BTD rs200337373 (3p25.1), KRT13 rs150321809 (17q21.2) and MC2R rs104894658 (18p11.21)), but only MC2R rs104894668 had a large effect size (OR = 9.66). Genes most strongly associated with EOC risk included ACTBL2 (P AML  = 3.23 × 10  -5 ; P SKAT-o  = 9.23 × 10  -4 ) and KRT13 (P AML  = 1.67 × 10  -4 ; P SKAT-o  = 1.07 × 10  -5 ), reaffirming variant-level analysis. In summary, this large study identified several rare and low-frequency variants and genes that may contribute to EOC susceptibility, albeit with possible small effects. Future studies that integrate epidemiology, sequencing, and functional assays are needed to further unravel the unexplained heritability and biology of this disease.
(© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
References: Mol Oncol. 2009 Apr;3(2):171-81. (PMID: 19383379)
Mol Cell Endocrinol. 2008 Dec 16;296(1-2):1-9. (PMID: 18951949)
Prostate. 2009 Jun 15;69(9):956-60. (PMID: 19267350)
Turk J Pediatr. 2013 Jul-Aug;55(4):443-6. (PMID: 24292042)
Nat Commun. 2014;5:3156. (PMID: 24448499)
PLoS One. 2012;7(7):e40956. (PMID: 22911723)
Nat Genet. 2010 Oct;42(10):874-9. (PMID: 20852632)
PLoS One. 2015 Oct 05;10(10):e0139642. (PMID: 26437075)
BMC Cancer. 2010 Mar 26;10:114. (PMID: 20346108)
Am J Hum Genet. 2008 Feb;82(2):290-303. (PMID: 18252211)
BMC Bioinformatics. 2015 Feb 20;16:53. (PMID: 25888290)
Future Oncol. 2006 Apr;2(2):257-74. (PMID: 16563094)
Neurobiol Aging. 2014 Aug;35(8):1958.e13-4. (PMID: 24685331)
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1822-30. (PMID: 20570913)
N Engl J Med. 2008 Jun 26;358(26):2796-803. (PMID: 18579814)
Cancer. 2011 Aug 1;117(15):3363-73. (PMID: 21319141)
Nat Genet. 2010 Oct;42(10):880-4. (PMID: 20852633)
BMC Bioinformatics. 2013 Jun 06;14:177. (PMID: 23738568)
Proc Natl Acad Sci U S A. 2003 Aug 5;100(16):9440-5. (PMID: 12883005)
Nat Genet. 2009 Sep;41(9):996-1000. (PMID: 19648919)
Nat Genet. 2013 Apr;45(4):362-70, 370e1-2. (PMID: 23535730)
Nat Genet. 2013 Feb;45(2):197-201. (PMID: 23263489)
Nature. 2011 Jun 29;474(7353):609-15. (PMID: 21720365)
Nat Genet. 2015 Aug;47(8):888-97. (PMID: 26075790)
Hum Mol Genet. 2014 Sep 1;23(17):4721-8. (PMID: 24728188)
Cancer Metab. 2014 Dec 15;2:21. (PMID: 25671108)
Hormones (Athens). 2014 Jan-Mar;13(1):140-5. (PMID: 24722135)
Biotechniques. 2002 Jun;Suppl:56-8, 60-1. (PMID: 12083399)
Nat Commun. 2014 Aug 19;5:4682. (PMID: 25134534)
Nat Genet. 2013 Apr;45(4):371-84, 384e1-2. (PMID: 23535731)
Gynecol Oncol. 2007 Sep;106(3):461-8. (PMID: 17624412)
Pac Symp Biocomput. 2014;:241-52. (PMID: 24297551)
Lancet. 1993 Feb 20;341(8843):461-2. (PMID: 8094489)
Genetics. 1984 Aug;107(4):703-18. (PMID: 6745643)
Nat Genet. 2006 Jun;38(6):659-62. (PMID: 16715099)
PLoS One. 2013 Jul 12;8(7):e68095. (PMID: 23874508)
Gynecol Endocrinol. 2014 Mar;30(3):192-6. (PMID: 24397395)
Nat Genet. 2004 Apr;36(4):388-93. (PMID: 15052270)
J Clin Oncol. 2015 Sep 10;33(26):2901-7. (PMID: 26261251)
BMC Genomics. 2011 Feb 01;12:92. (PMID: 21284873)
Front Physiol. 2014 Dec 03;5:467. (PMID: 25520667)
Bioinformatics. 2012 Oct 1;28(19):2543-5. (PMID: 22843986)
Am J Hum Genet. 2011 Jul 15;89(1):82-93. (PMID: 21737059)
J Natl Cancer Inst. 2015 Aug 27;107(11):. (PMID: 26315354)
Br J Obstet Gynaecol. 1998 May;105(5):493-9. (PMID: 9637117)
Mol Genet Metab. 2013 Nov;110(3):248-54. (PMID: 24075304)
Am J Hum Genet. 2011 Jan 7;88(1):76-82. (PMID: 21167468)
J Clin Endocrinol Metab. 2012 May;97(5):E747-54. (PMID: 22419722)
Am J Hum Genet. 2012 Aug 10;91(2):224-37. (PMID: 22863193)
Genet Epidemiol. 2006 Nov;30(7):636-43. (PMID: 16986161)
Am J Hum Genet. 2007 Apr;80(4):727-39. (PMID: 17357078)
Nat Commun. 2013;4:1627. (PMID: 23535648)
Nat Commun. 2013;4:1628. (PMID: 23535649)
Int J Oncol. 2012 Oct;41(4):1373-80. (PMID: 22842514)
Nat Genet. 2015 Feb;47(2):164-71. (PMID: 25581431)
معلومات مُعتمدة: 10124 United Kingdom CRUK_ Cancer Research UK; R01 CA087538 United States CA NCI NIH HHS; K07 CA092044 United States CA NCI NIH HHS; K07 CA080668 United States CA NCI NIH HHS; P30 CA008748 United States CA NCI NIH HHS; P30 CA076292 United States CA NCI NIH HHS; R03 CA115195 United States CA NCI NIH HHS; R01 CA076016 United States CA NCI NIH HHS; R01 CA087696 United States CA NCI NIH HHS; U19 CA148112 United States CA NCI NIH HHS; R01 CA049449 United States CA NCI NIH HHS; N01 CN025403 United States CN NCI NIH HHS; N01 PC067010 United States PC NCI NIH HHS; P50 CA159981 United States CA NCI NIH HHS; P30 CA046592 United States CA NCI NIH HHS; M01 RR000056 United States RR NCRR NIH HHS; P30 CA072720 United States CA NCI NIH HHS; R01 CA095023 United States CA NCI NIH HHS; R37 CA070867 United States CA NCI NIH HHS; R03 CA113148 United States CA NCI NIH HHS; R01 CA058598 United States CA NCI NIH HHS; K22 CA138563 United States CA NCI NIH HHS; R01 CA058860 United States CA NCI NIH HHS; P50 CA105009 United States CA NCI NIH HHS; R01 CA178535 United States CA NCI NIH HHS; P30 CA014089 United States CA NCI NIH HHS; R01 CA083918 United States CA NCI NIH HHS; R01 CA054419 United States CA NCI NIH HHS; R01 CA122443 United States CA NCI NIH HHS; P30 CA015083 United States CA NCI NIH HHS; 16561 United Kingdom CRUK_ Cancer Research UK; P01 CA017054 United States CA NCI NIH HHS; Z01 ES044005 United States ImNIH Intramural NIH HHS; UM1 CA182910 United States CA NCI NIH HHS; K07 CA095666 United States CA NCI NIH HHS; P30 CA071789 United States CA NCI NIH HHS; R01 CA112523 United States CA NCI NIH HHS; P50 CA136393 United States CA NCI NIH HHS; R01 CA126841 United States CA NCI NIH HHS; 10119 United Kingdom CRUK_ Cancer Research UK
المشرفين على المادة: 0 (ACTC1 protein, human)
0 (Actins)
0 (KRT13 protein, human)
0 (Keratin-13)
0 (Neoplasm Proteins)
0 (Receptor, Melanocortin, Type 2)
EC 3.5.1.12 (Biotinidase)
تواريخ الأحداث: Date Created: 20160706 Date Completed: 20170713 Latest Revision: 20240615
رمز التحديث: 20240615
مُعرف محوري في PubMed: PMC5179948
DOI: 10.1093/hmg/ddw196
PMID: 27378695
قاعدة البيانات: MEDLINE
الوصف
تدمد:1460-2083
DOI:10.1093/hmg/ddw196